Microbix granted patent on its Vaccine Technology
Microbix Biosystems Inc. announced that it has been granted a patent by the Canadian Patent Office for its Vaccine Technology. This technology holds the promise of significantly boosting global production of influenza vaccines.
"This is a major milestone for Microbix as we move towards commercializing this important technology," said William J. Gastle, Chairman and CEO of the Company. "This is the first of a series of patents we expect will be granted in international markets where influenza vaccines are manufactured."
Last year, an independent laboratory confirmed that the Microbix' vaccine technology delivers a two-fold increase in the yield of human influenza virus from eggs. The independent evaluation was conducted by Dr. Todd Hatchette, the Director of Virology and Immunology at the Queen Elizabeth II Health Sciences Centre in Halifax, Nova Scotia. Dr. Hatchette is a specialist in the field of influenza virus.
Most read news
Other news from the department research and development
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
BD Biosciences Announces Agreement with Dynomics to Collaborate on Novel Cancer Diagnostic Technology
FLUOstar Omega | Microplate readers | BMG Labtech
Electrocatalysis under the atomic force microscope - More insights with AFM
How to amplify or stifle signals for immune responses
Voice-activated system for hands-free, safer DNA handling - Technology protects researchers from dangerous samples
Enough is enough - Stem cell factor Nanog knows when to slow down
Tiny Helpers that Clean Cells - Proteins that assist the natural recycling process in the body
Cellular Communication Agent - Tracking the NO signaling pathway